Harrow (HROW) Capital Expenditures (2012 - 2026)
Harrow's Capital Expenditures was $491,000 in Q2 2026, up 195.8% from $166,000 a year earlier and up 153.1% from the prior quarter.
Powered by 
Analysis
Harrow (HROW) Capital Expenditures (2012 - 2026) Analysis & Trends
On a trailing twelve-month basis, Harrow's Capital Expenditures was $1.24 million through Jun 30, 2026, down 17.3% year-over-year; for FY2025, it came in at $887,000, down 44.4% from FY2024.
- Capital Expenditures shows a five-year compound annual growth rate of 0.6% (FY2020 to FY2025).
- In earlier years, Capital Expenditures was $1.6 million in FY2024 (+9.2%), $1.46 million in FY2023 (-43.8%), $2.6 million in FY2022 (+45.4%) and $1.79 million in FY2021 (+107.2%).
- The Q2 2026 figure marks the highest quarterly Capital Expenditures since Q4 2024.
- Compared with a year earlier, Capital Expenditures was higher in five of the last eight quarters, with growth averaging 42.7%.
- The best year-over-year quarter for Capital Expenditures over five years was Q4 2022 (growth of 540.9%); the worst was Q1 2024 (a decline of 81.5%).
- Per Business Quant data, HROW's Capital Expenditures in the three quarters before Q2 2026 was $194,000 (Q1 2026), $341,000 (Q4 2025) and $210,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 3.18 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 1.36 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 301.00 Mn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 1.04 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | -3.30 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 587.00 Mn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 237.00 Mn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 573.00 Mn |
| 10 | Harrow | 1.03 Bn | 708.48 Mn | 50.36 Mn | 491,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 491,000.00 |
| Mar 31, 2026 | 194,000.00 |
| Dec 31, 2025 | 341,000.00 |
| Sep 30, 2025 | 210,000.00 |
| Jun 30, 2025 | 166,000.00 |
| Mar 31, 2025 | 170,000.00 |
| Dec 31, 2024 | 555,000.00 |
| Sep 30, 2024 | 604,000.00 |
| Jun 30, 2024 | 344,000.00 |
| Mar 31, 2024 | 92,000.00 |
| Dec 31, 2023 | 194,000.00 |
| Sep 30, 2023 | 520,000.00 |
| Jun 30, 2023 | 250,000.00 |
| Mar 31, 2023 | 496,000.00 |
| Dec 31, 2022 | 878,000.00 |
| Sep 30, 2022 | 1.06 Mn |
| Jun 30, 2022 | 260,000.00 |
| Mar 31, 2022 | 404,000.00 |
| Dec 31, 2021 | 137,000.00 |
| Sep 30, 2021 | 289,000.00 |
API Access
Harrow Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=HROW&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "HROW", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=HROW&period=max&api_key=YOUR_API_KEY");
const data = await res.json();